Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ingrid Pabinger

Showing results (351-360 of 367) with videos related to

Pageof 37
Sort By:
The Lancet. Oncology|June 30, 2022
2022 international clinical practice guidelines for the treatment and prophylaxis of venous thromboembolism in patients with cancer, including patients with COVID-19Dominique Farge, Corinne Frere, Jean M Connors, et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia|October 22, 2022
Applicability of the European Society of Cardiology Guidelines on the management of acute coronary syndromes to older people with haemophilia A - A modified Delphi consensus by the ADVANCE Working GroupRobert Klamroth, Cihan Ay, Philippe De Moerloose, et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia|February 21, 2023
Prevalence of COVID-19 related hospitalizations and mortality in adults aged ≥40 years with haemophilia: A survey from EuropeCedric Hermans, Jan Astermark, Manuela Carvalho, et al.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|September 5, 2022
Interleukin-4 receptor alpha signaling regulates monocyte homeostasisPatrick Haider, Julia B Kral-Pointner, Manuel Salzmann, et al.
Journal of Thrombosis and Haemostasis : JTH|March 22, 2024
Standardization of definition and management for bleeding disorder of unknown cause: communication from the SSC of the ISTHRoss I Baker, Philip Choi, Nicola Curry, et al.
Blood Advances|May 9, 2022
The bleeding phenotype in people with nonsevere hemophiliaFabienne R Kloosterman, Anne-Fleur Zwagemaker, Catherine N Bagot, et al.
Journal of Thrombosis and Haemostasis : JTH|September 2, 2024
Biomarker-enhanced cardiovascular risk prediction in patients with cancer: a prospective cohort studySimon Kraler, Luca Liberale, Stephan Nopp, et al.
Thrombosis and Haemostasis|August 15, 2015
Edoxaban for treatment of venous thromboembolism in patients with cancer. Rationale and design of the Hokusai VTE-cancer studyNick van Es, Marcello Di Nisio, Suzanne M Bleker, et al.
Hemasphere|March 26, 2025
Mild or moderate hemophilia is not always a mild or moderate bleeding disorder: Back to the clinical phenotypeFrancesco Rodeghiero, Lisanna Ghiotto, Luca Pontalto, et al.
Cardiovascular Research|October 5, 2021
Low-molecular-weight heparin use in coronavirus disease 2019 is associated with curtailed viral persistence: a retrospective multicentre observational studyDavid Pereyra, Stefan Heber, Waltraud C Schrottmaier, et al.
Pageof 37

Showing results (351-360 of 367) with videos related to

Sort By:
Pageof 37
The Lancet. Oncology|June 30, 2022
2022 international clinical practice guidelines for the treatment and prophylaxis of venous thromboembolism in patients with cancer, including patients with COVID-19Dominique Farge, Corinne Frere, Jean M Connors, et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia|October 22, 2022
Applicability of the European Society of Cardiology Guidelines on the management of acute coronary syndromes to older people with haemophilia A - A modified Delphi consensus by the ADVANCE Working GroupRobert Klamroth, Cihan Ay, Philippe De Moerloose, et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia|February 21, 2023
Prevalence of COVID-19 related hospitalizations and mortality in adults aged ≥40 years with haemophilia: A survey from EuropeCedric Hermans, Jan Astermark, Manuela Carvalho, et al.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|September 5, 2022
Interleukin-4 receptor alpha signaling regulates monocyte homeostasisPatrick Haider, Julia B Kral-Pointner, Manuel Salzmann, et al.
Journal of Thrombosis and Haemostasis : JTH|March 22, 2024
Standardization of definition and management for bleeding disorder of unknown cause: communication from the SSC of the ISTHRoss I Baker, Philip Choi, Nicola Curry, et al.
Blood Advances|May 9, 2022
The bleeding phenotype in people with nonsevere hemophiliaFabienne R Kloosterman, Anne-Fleur Zwagemaker, Catherine N Bagot, et al.
Journal of Thrombosis and Haemostasis : JTH|September 2, 2024
Biomarker-enhanced cardiovascular risk prediction in patients with cancer: a prospective cohort studySimon Kraler, Luca Liberale, Stephan Nopp, et al.
Thrombosis and Haemostasis|August 15, 2015
Edoxaban for treatment of venous thromboembolism in patients with cancer. Rationale and design of the Hokusai VTE-cancer studyNick van Es, Marcello Di Nisio, Suzanne M Bleker, et al.
Hemasphere|March 26, 2025
Mild or moderate hemophilia is not always a mild or moderate bleeding disorder: Back to the clinical phenotypeFrancesco Rodeghiero, Lisanna Ghiotto, Luca Pontalto, et al.
Cardiovascular Research|October 5, 2021
Low-molecular-weight heparin use in coronavirus disease 2019 is associated with curtailed viral persistence: a retrospective multicentre observational studyDavid Pereyra, Stefan Heber, Waltraud C Schrottmaier, et al.
Pageof 37